SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
22 hedge funds and large institutions have $67M invested in Sierra Oncology, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-7
Holders Change %
-24.14%
% of All Funds
0.49%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
11
Increased
4
Reduced
5
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VC
Vivo Capital
Palo Alto,
California
|
+$18.8M |
2 |
O
OrbiMed
New York
|
+$14.5M |
3 |
A
Abingworth
London,
United Kingdom
|
+$8.54M |
4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$6.32M |
5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$4.32M |
Top Sellers
1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$470K |
2 |
HP
Hikari Power
Tokyo,
Japan
|
-$171K |
3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$132K |
4 |
GT
Greenleaf Trust
Kalamazoo,
Michigan
|
-$74K |
5 |
WG
Winton Group
London,
United Kingdom
|
-$62K |